ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

821 - 840 out of 1,024 results.

SCIESCOPUS
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

Barlesi, F[Barlesi, Fabrice]; Scherpereel, A[Scherpereel, Arnaud]; Rittmeyer, A[Rittmeyer, Achim]; Pazzola, A[Pazzola, Antonio]; Tur, NF[Tur, Neus Ferrer]; Kim, JH[Kim, Joo-Hang]; Ahn, MJ[Ahn, Myung-Ju]; Aerts, JGJV[Aerts, Joachim G. J. V.]; Gorbunova, V[Gorbunova, Vera]; Vikstrom, A[Vikstrom, Anders], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.24, pp.3004 - U109PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III trial of a 3-weekly versus 5-weekly schedule of S-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOS study.

Ryu, MH[Ryu, Min-Hee]; Baba, E[Baba, Eishi]; Lee, KH[Lee, Kyung Hee]; Boku, N[Boku, Narikazu]; Park, YL[Park, Young Lee]; Hyodo, I[Hyodo, Ichinosuke]; Nam, BH[Nam, Byung-Ho]; Esaki, T[Esaki, Taito]; Ryoo, BY[Ryoo, Baek-Yeol]; Song, EK[Song, Eun-Kee], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.18PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.

Hecht, JR[Hecht, J. Randolph]; Bang, YJ[Bang, Yung-Jue]; Qin, S[Qin, Shukui]; Chung, HC[Chung, Hyun-Chul]; Xu, JM[Xu, Jian-Ming]; Park, JO[Park, Joon Oh]; Jeziorski, K[Jeziorski, Krzysztof]; Shparyk, Y[Shparyk, Yaroslav]; Hoff, PM[Hoff, Paulo M.]; Sobrero, AF[Sobrero, Alberto F.], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.18PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.

Stupp, R[Stupp, Roger]; Hegi, ME[Hegi, Monika E.]; Gorlia, T[Gorlia, Thierry]; Erridge, S[Erridge, Sara]; Grujicic, D[Grujicic, Danica]; Steinbach, JP[Steinbach, Joachim Peter]; Wick, W[Wick, Wolfgang]; Tarnawski, R[Tarnawski, Rafal]; Nam, DH[Nam, Do-Hyun]; Weyerbrock, A[Weyerbrock, Astrid], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.18PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Ohmachi, K[Ohmachi, Ken]; Niitsu, N[Niitsu, Nozomi]; Uchida, T[Uchida, Toshiki]; Kim, SJ[Kim, Seok Jin]; Ando, K[Ando, Kiyoshi]; Takahashi, N[Takahashi, Naoki]; Takahashi, N[Takahashi, Naoto]; Uike, N[Uike, Naokuni]; Eom, HS[Eom, Hyeon Seok]; Chae, YS[Chae, Yee Soo], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.17, pp.2103 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Conservative management of young women with endometrial adenocarcinoma with grade 2-3 and/or superficial myometrial invasion

Park, JY[Park, Jeong-Yeol]; Kim, DY[Kim, Dae-Yeon]; Kim, TJ[Kim, Tae-Jin]; Kim, JW[Kim, Jae Weon]; Kim, JH[Kim, Jong-Hyeok]; Kim, YM[Kim, Yong -Man]; Kim, YT[Kim, Young-Tak]; Bae, DS[Bae, Duk-Soo]; Nam, JH[Nam, Joo-Hyun]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Clinical outcome according to tumor HER2 status and EGFR expression in advanced gastric cancer patients from the EXPAND study

Lordick, F[Lordick, Florian]; Kang, YK[Kang, Yoon-Koo]; Salman, P[Salman, Pamela]; Oh, SC[Oh, Sang Cheul]; Bodoky, G[Bodoky, Gyorgy]; Kurteva, GP[Kurteva, Galina Petrova]; Volovat, CD[Volovat, Constantin D.]; Moiseyenko, V[Moiseyenko, Vladimir]; Sawaki, A[Sawaki, Akira]; Park, JO[Park, Joon Oh], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation: Final results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.

Stupp, R[Stupp, Roger]; Hegi, ME[Hegi, Monika E.]; Goriia, T[Goriia, Thierry]; Erridge, S[Erridge, Sara]; Grujicic, D[Grujicic, Danica]; Steinbach, JP[Steinbach, Joachim Peter]; Wick, W[Wick, Wolfgang]; Tarnawski, R[Tarnawski, Rafal]; Nam, DH[Nam, Do-Hyun]; Weyerbrock, A[Weyerbrock, Astrid], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III trial of a 3-weekly versus 5-weekly schedule of S-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOS study.

Ryu, MH[Ryu, Min-Hee]; Baba, E[Baba, Eishi]; Lee, KH[Lee, Kyung Hee]; Boku, N[Boku, Narikazu]; Park, YL[Park, Young Lee]; Hyodo, I[Hyodo, Ichinosuke]; Nam, BH[Nam, Byung-Ho]; Esaki, T[Esaki, Taito]; Ryoo, BY[Ryoo, Baek-Yeol]; Song, EK[Song, Eun-Kee], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Effect of maintenance bevacizumab (Bev) plus pemetrexed (Pem) after first-line cisplatin/Pem/Bev in advanced nonsquamous non-small cell lung cancer (nsNSCLC) on overall survival (OS) of patients (pts) on the AVAPERL (MO22089) phase III randomized trial.

Rittmeyer, A[Rittmeyer, Achim]; Scherpereel, A[Scherpereel, Arnaud]; Gorbunova, VA[Gorbunova, Vera A.]; Gervais, R[Gervais, Radj]; Vikstrom, A[Vikstrom, Anders]; Chouaid, C[Chouaid, Christos]; Chella, A[Chella, Antonio]; Kim, JH[Kim, Joo-Hang]; Ahn, MJ[Ahn, Myung-Ju]; Reck, M[Reck, Martin], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
CA184-104: Randomized, multicenter, double-blind, phase III trial comparing the efficacy of ipilimumab (Ipi) with paclitaxel/carboplatin (PC) versus placebo with PC in patients (pts) with stage IV/recurrent non-small cell lung cancer (NSCLC) of squamous histology.

Reck, M[Reck, Martin]; Gonzalez-Mella, P[Gonzalez-Mella, Pablo]; Ahn, MJ[Ahn, Myung-Jo]; Ghazal, HH[Ghazal, Hassan H.]; Schneider, CP[Schneider, Claus-Peter]; Jassem, J[Jassem, Jacek]; Lu, HL[Lu, Haolan]; McDowell, DO[McDowell, Diane Opatt]; Postmus, PE[Postmus, Pieter E.]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Global clinical experience with adjuvant oxaliplatin/5-fluorouracil (5-FU)-based chemotherapy for colon cancer: Outcomes of the ACCElox registry.

Park, YS[Park, Young Suk]; Ji, JF[Ji, Jiafu]; Zalcberg, JR[Zalcberg, John Raymond]; Elserafy, MM[Elserafy, Mostafa M.]; Buzaid, AC[Buzaid, Antonio C.]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) patients who received taxane plus trastuzumab treatment

Park, YH[Park, Yeon Hee]; Jung, HA[Jung, Hyun As]; Chang, WJ[Chang, Won Jin]; Choi, MK[Choi, Moon Ki]; Hong, JY[Hong, Jung Yong]; Ok, ON[Ok, Oh-Nam]; Seo, JJ[Seo, Jeong Ju]; Choi, YL[Choi, Yoon-La]; Do, I[Do, Ingu]; Ahn, JS[Ahn, Jun Seok], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Defining parameters that can guide public cord blood units (CBUs) in Korea.

Lee, J[Lee, Junglim]; Ji, JH[Ji, Jun Ho]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Comparison of clinical outcome between gefitinib and erlotinib treatment in patients with non-small cell lung cancer harboring an epidermal growth factor receptor exon 19 or exon 21 mutations

Lim, SH[Lim, Sung Hee]; Lee, JY[Lee, Ji Yoon]; Sun, JM[Sun, Jong-Mu]; Ahn, JS[Ahn, Jin Seok]; Park, K[Park, Keunchil]; Ahn, MJ[Ahn, Myung-Ju]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A plus AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL).

Younes, A[Younes, Anas]; Radford, J[Radford, John]; Ansell, SM[Ansell, Stephen Maxted]; Gallamini, A[Gallamini, Andrea]; Kim, WS[Kim, Won Seog]; Feldman, TA[Feldman, Tatyana A.]; Hamadani, M[Hamadani, Mehdi]; Chung, J[Chung, Jeanenne]; Wang, JY[Wang, Jingyuan]; Huebner, D[Huebner, Dirk], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase Ib dose-escalation study of Pexa-Vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, administered by intravenous (IV) infusions in patients with metastatic colorectal carcinoma (mCRC)

Lee, J[Lee, Jeeyun]; Park, YS[Park, Young Suk]; Burke, J[Burke, James]; Lim, HY[Lim, Ho Yeong]; Lee, J[Lee, Jihye]; Kang, WK[Kang, Won Ki]; Park, JO[Park, Joon Oh]; Pelusio, A[Pelusio, Adina]; Breitbach, C[Breitbach, Caroline]; Kirn, DH[Kirn, David H.]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A phase II trial of weekly docetaxel for second-line treatment of urothelial carcinoma.

Kim, YS[Kim, Young Saing]; Choi, MK[Choi, Moon Ki]; Hong, JY[Hong, Jung Yong]; Maeng, CH[Maeng, Chi Hoon]; Lee, S[Lee, Soonil]; Hwang, IG[Hwang, In Gyu]; Lee, SC[Lee, Sang-Cheol]; Sun, JM[Sun, Jong-Mu]; Park, SH[Park, Se Hoon]; Lee, J[Lee, Jeeyun], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
An open label, randomized, parallel, phase II trial to evaluate the efficacy and safety of cremophor-free, polymeric micelle formulation of paclitaxel compared to paclitaxel in subjects with ovarian cancer.

Kim, YM[Kim, Yong-Man]; Lee, SW[Lee, Shin-Wha]; Cho, CH[Cho, Chi Heum]; Hur, SY[Hur, Soo-Young]; Kim, BG[Kim, Byoung-Gie]; Kim, JH[Kim, Jae Hoon]; Kim, SC[Kim, Seung Cheol]; Kim, SM[Kim, Seok-Mo]; Kim, YT[Kim, Young-Tae]; Ryu, HS[Ryu, Hee Sug], et al.

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.

Kim, SH[Kim, Seok-Hyun]; Lee, GW[Lee, Gyeong-Won]; Jeong, YY[Jeong, Yi Yeong]; Kim, HC[Kim, Ho-Cheol]; Lee, JD[Lee, Jong Deog]; Hwang, YS[Hwang, Young Sil]; Kim, IS[Kim, In-Suk]; Lee, S[Lee, Suee]; Oh, SY[Oh, Sung Yong]

ArticleIssue Date2013CitationJOURNAL OF CLINICAL ONCOLOGY, v.31, no.15PublisherAMER SOC CLINICAL ONCOLOGY
first 41 42 43 44 45 46 47 48 49 50 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어